GLN-DOCOSANOL
Natural health product licensed in Canada
- Licence holder
- Glenmark Pharmaceuticals Canada Inc.
- NPN or DIN-HM
- 80124828
- Status
- Active licence
- Licence date
- 7 June 2023
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 1-docosanol | 10 % (p/p) |
Non-medicinal ingredients
Alcool benzylique, Stéarate de saccharose, alpha-D-glucopyranoside, beta-D-fructofuranosyle, dioctadécanoate, Eau purifiée, Huile minérale légère, Propylène glycol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants, adolescents et adultes | minimum: 12 years | 1 Crème | 5 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Cold Sore Treatment. For the treatment of acute episodes of recurrent oral-facial herpes simplex (fever blisters or cold sores). Treats cold sores / fever blisters on the lips and face. For the treatment of recurrent cold sores. Docosanol is clinically proven to shorten the healing time (duration) of your cold sore. Shortens healing time and the duration of cold sore symptoms including pain, burning, tingling and itching. Reduces the duration of pain, burning, itching and tingling associated with cold sores. Clinically proven to speed cold sore healing. The predominant mechanism for the anti-HSV activity of docosanol appears to be inhibition of fusion between the plasma membrane and the HSV envelope, which helps to treat cold sores. Blocks viral entry into the cell and subsequent viral replication, thereby helping to treat cold sores. Viral Entry Blocking Agent to help treat cold sores. Inhibits entry of the cold sore virus into surrounding cells to help treat cold sores. Docosanol is a substance which blocks the ability of the cold sore virus to enter your skin cells, limiting its ability to spread to surrounding cells and thereby helping to treat cold sores. Docosanol soothes cold sores on contact.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80124828
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.